Top News
Latest News
INNOVATION
12 Dec 2025
CRISPR Breakthrough Brings Gene Editing Closer to Daily CareTECHNOLOGY
10 Dec 2025
AI Turbocharges Metagenomi’s CRISPR QuestINSIGHTS
24 Nov 2025
Lipid Cuts, Big Deals, and a New CRISPR EraINNOVATION
19 Nov 2025
CRISPR GPT Sparks a Faster Era in Biotech Research
Can a New Pact Propel Gene Editing Into Its Next Era?
INVESTMENT
17 Nov 2025
AstraZeneca and Algen team up on gene editing and AI to tackle immune diseases
PARTNERSHIPS
28 Oct 2025
One Infant, One Breakthrough: CRISPR Enters a New Phase
Acuitas, CHOP, and Penn pioneer safer, patient-tailored base editing through a landmark CRISPR collaboration
MARKET TRENDS
7 Aug 2025
Gene Editing’s Next Battle: Cracking the Delivery Code
Biotech firms like Intellia and Editas race to crack CRISPR delivery, a key to market dominance and future gene therapy breakthroughs.
INVESTMENT
30 Jul 2025
Lilly Bets $1.3B on One-Shot Cure for Heart Disease
Lilly buys Verve Therapeutics to chase a one-time gene edit that could end lifelong cholesterol treatment.
TECHNOLOGY
16 Jul 2025
AI and CRISPR: A Partnership Set to Rewrite Biotech
AI is reshaping how CRISPR therapies reach cells, cutting delays and boosting safety in the race for next-gen gene editing.
PARTNERSHIPS
10 Jul 2025
AbbVie Goes All In on In-Body Gene Therapy
AbbVie acquires Capstan to unlock in-vivo gene delivery and transform autoimmune treatment with faster, easier therapies.
RESEARCH
4 Jul 2025
One Injection, Decades of Heart Protection?
CRISPR therapy cuts LDL by 86% in a single dose, hinting at a future where gene editing replaces daily heart meds.
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.